TY - JOUR AU - Ho, M. PY - 2016 DA - 2016// TI - A framework for incorporating patient preferences regarding benefits and risks into regulatory assessment of medical technologies JO - Value Health VL - 19 UR - https://doi.org/10.1016/j.jval.2016.02.019 DO - 10.1016/j.jval.2016.02.019 ID - Ho2016 ER - TY - STD TI - US Food and Drug Administration. Patient preference information – voluntary submission, review in premarket approval applications, humanitarian device exemption applications, and de novo requests, and inclusion in decision summaries and device labeling, issued August 2016. (https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM446680.pdf). UR - https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM446680.pdf ID - ref2 ER - TY - STD TI - European Medicines Agency. The Patient’s Voice in the Evaluation of Medicines: How Patients Can Contribute to Assessment of Benefit and Risk, issued October 2013. (http://www.ema.europa.eu/docs/en_GB/document_library/Report/2013/10/WC500153276.pdf). UR - http://www.ema.europa.eu/docs/en_GB/document_library/Report/2013/10/WC500153276.pdf ID - ref3 ER - TY - JOUR AU - Danner, M. PY - 2011 DA - 2011// TI - Integrating patients' views into health technology assessment: analytic hierarchy process (HAP) as a method to elicit patient preferences JO - Int J Technol Assess Health Care VL - 27 UR - https://doi.org/10.1017/S0266462311000523 DO - 10.1017/S0266462311000523 ID - Danner2011 ER - TY - STD TI - Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes: Oxford university press; 2015. ID - ref5 ER - TY - JOUR AU - Brett Hauber, A. AU - Fairchild, A. O. AU - Reed Johnson, F. PY - 2013 DA - 2013// TI - Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature JO - Appl Health Econ Health Policy VL - 11 UR - https://doi.org/10.1007/s40258-013-0028-y DO - 10.1007/s40258-013-0028-y ID - Brett Hauber2013 ER - TY - STD TI - US Food and Drug Administration. Factors to consider when making benefit-risk determinations in medical device premarket approval and de NovoClassifications, issued August. 2016. https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-meddev-gen/documents/document/ucm517504.pdf. UR - https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-meddev-gen/documents/document/ucm517504.pdf ID - ref7 ER - TY - JOUR AU - Yepes-Nuñez, J. J. PY - 2017 DA - 2017// TI - Forty-two systematic reviews generated 23 items for assessing the risk of bias in values and preferences' studies JO - J Clin Epidemiol VL - 85 UR - https://doi.org/10.1016/j.jclinepi.2017.04.019 DO - 10.1016/j.jclinepi.2017.04.019 ID - Yepes-Nuñez2017 ER - TY - JOUR AU - Montori, V. M. PY - 2005 DA - 2005// TI - Optimal search strategies for retrieving systematic reviews from Medline: analytical survey JO - BMJ VL - 330 UR - https://doi.org/10.1136/bmj.38336.804167.47 DO - 10.1136/bmj.38336.804167.47 ID - Montori2005 ER - TY - JOUR AU - Van Brunt, K. PY - 2011 DA - 2011// TI - Preferences related to attention-deficit/hyperactivity disorder and its treatment JO - Patient Prefer Adherence VL - 5 ID - Van Brunt2011 ER - TY - JOUR AU - Belinchon, I. PY - 2016 DA - 2016// TI - Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature JO - Patient Prefer Adherence VL - 10 UR - https://doi.org/10.2147/PPA.S117006 DO - 10.2147/PPA.S117006 ID - Belinchon2016 ER - TY - JOUR AU - Bereza, B. G. PY - 2015 DA - 2015// TI - Patient preferences in severe COPD and asthma: a comprehensive literature review JO - Int J Chron Obstruct Pulmon Dis VL - 10 ID - Bereza2015 ER - TY - JOUR AU - Blanchard, P. PY - 2016 DA - 2016// TI - Assessing head and neck cancer patient preferences and expectations: a systematic review JO - Oral Oncol VL - 62 UR - https://doi.org/10.1016/j.oraloncology.2016.09.008 DO - 10.1016/j.oraloncology.2016.09.008 ID - Blanchard2016 ER - TY - JOUR AU - Blinman, P. PY - 2010 DA - 2010// TI - Patients' preferences for chemotherapy in non-small-cell lung cancer: a systematic review JO - Lung Cancer VL - 69 UR - https://doi.org/10.1016/j.lungcan.2010.05.001 DO - 10.1016/j.lungcan.2010.05.001 ID - Blinman2010 ER - TY - JOUR AU - Bradley, N. M. PY - 2007 DA - 2007// TI - Review of patterns of practice and patients' preferences in the treatment of bone metastases with palliative radiotherapy JO - Support Care Cancer VL - 15 UR - https://doi.org/10.1007/s00520-006-0161-3 DO - 10.1007/s00520-006-0161-3 ID - Bradley2007 ER - TY - JOUR AU - Brooker, A. S. PY - 2013 DA - 2013// TI - Quantitative patient preference evidence for health technology assessment: a case study JO - Int J Technol Assess Health Care VL - 29 UR - https://doi.org/10.1017/S0266462313000329 DO - 10.1017/S0266462313000329 ID - Brooker2013 ER - TY - JOUR AU - Currie, A. PY - 2015 DA - 2015// TI - A systematic review of patient preference elicitation methods in the treatment of colorectal cancer JO - Color Dis VL - 17 UR - https://doi.org/10.1111/codi.12754 DO - 10.1111/codi.12754 ID - Currie2015 ER - TY - JOUR AU - Damm, K. AU - Vogel, A. AU - Prenzler, A. PY - 2014 DA - 2014// TI - Preferences of colorectal cancer patients for treatment and decision-making: a systematic literature review JO - Eur J Cancer Care (Engl) VL - 23 UR - https://doi.org/10.1111/ecc.12207 DO - 10.1111/ecc.12207 ID - Damm2014 ER - TY - JOUR AU - Eek, D. PY - 2016 DA - 2016// TI - Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature JO - Patient Prefer Adherence VL - 10 UR - https://doi.org/10.2147/PPA.S106629 DO - 10.2147/PPA.S106629 ID - Eek2016 ER - TY - JOUR AU - Eiring, O. PY - 2015 DA - 2015// TI - What matters to patients? A systematic review of preferences for medication-associated outcomes in mental disorders JO - BMJ Open VL - 5 UR - https://doi.org/10.1136/bmjopen-2015-007848 DO - 10.1136/bmjopen-2015-007848 ID - Eiring2015 ER - TY - JOUR AU - Emberton, M. PY - 2010 DA - 2010// TI - Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction JO - Int J Clin Pract VL - 64 UR - https://doi.org/10.1111/j.1742-1241.2010.02463.x DO - 10.1111/j.1742-1241.2010.02463.x ID - Emberton2010 ER - TY - JOUR AU - Gutknecht, M. PY - 2016 DA - 2016// TI - A systematic review on methods used to evaluate patient preferences in psoriasis treatments JO - J Eur Acad Dermatol Venereol VL - 30 UR - https://doi.org/10.1111/jdv.13749 DO - 10.1111/jdv.13749 ID - Gutknecht2016 ER - TY - JOUR AU - Hamelinck, V. C. PY - 2014 DA - 2014// TI - Patients' preferences for surgical and adjuvant systemic treatment in early breast cancer: a systematic review JO - Cancer Treat Rev VL - 40 UR - https://doi.org/10.1016/j.ctrv.2014.06.007 DO - 10.1016/j.ctrv.2014.06.007 ID - Hamelinck2014 ER - TY - JOUR AU - Joy, S. M. PY - 2013 DA - 2013// TI - Patient preferences for the treatment of type 2 diabetes: a scoping review JO - PharmacoEconomics VL - 31 UR - https://doi.org/10.1007/s40273-013-0089-7 DO - 10.1007/s40273-013-0089-7 ID - Joy2013 ER - TY - JOUR AU - Lytvyn, L. PY - 2016 DA - 2016// TI - Patient values and preferences on transcatheter or surgical aortic valve replacement therapy for aortic stenosis: a systematic review JO - BMJ Open VL - 6 UR - https://doi.org/10.1136/bmjopen-2016-014327 DO - 10.1136/bmjopen-2016-014327 ID - Lytvyn2016 ER - TY - JOUR AU - MacLean, S. PY - 2012 DA - 2012// TI - Patient values and preferences in decision making for antithrombotic therapy: a systematic review: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines JO - Chest VL - 141 UR - https://doi.org/10.1378/chest.11-2290 DO - 10.1378/chest.11-2290 ID - MacLean2012 ER - TY - JOUR AU - Mansfield, C. PY - 2016 DA - 2016// TI - Stated preference for cancer screening: a systematic review of the literature, 1990-2013 JO - Prev Chronic Dis VL - 13 UR - https://doi.org/10.5888/pcd13.150433 DO - 10.5888/pcd13.150433 ID - Mansfield2016 ER - TY - JOUR AU - Phillips, K. A. PY - 2006 DA - 2006// TI - A review of studies examining stated preferences for cancer screening JO - Prev Chronic Dis VL - 3 ID - Phillips2006 ER - TY - JOUR AU - Purnell, T. S. PY - 2014 DA - 2014// TI - Patient preferences for noninsulin diabetes medications: a systematic review JO - Diabetes Care VL - 37 UR - https://doi.org/10.2337/dc13-2527 DO - 10.2337/dc13-2527 ID - Purnell2014 ER - TY - JOUR AU - Sadique, M. Z. AU - Legood, R. PY - 2012 DA - 2012// TI - Women's preferences regarding options for management of atypical, borderline or low-grade cervical cytological abnormalities: a review of the evidence JO - Cytopathology VL - 23 UR - https://doi.org/10.1111/j.1365-2303.2011.00873.x DO - 10.1111/j.1365-2303.2011.00873.x ID - Sadique2012 ER - TY - JOUR AU - Schatz, N. K. PY - 2015 DA - 2015// TI - Systematic review of Patients' and Parents' preferences for ADHD treatment options and processes of care JO - Patient VL - 8 UR - https://doi.org/10.1007/s40271-015-0112-5 DO - 10.1007/s40271-015-0112-5 ID - Schatz2015 ER - TY - JOUR AU - Schmidt, K. PY - 2016 DA - 2016// TI - Preferences of lung cancer patients for treatment and decision-making: a systematic literature review JO - Eur J Cancer Care (Engl) VL - 25 UR - https://doi.org/10.1111/ecc.12425 DO - 10.1111/ecc.12425 ID - Schmidt2016 ER - TY - JOUR AU - Showalter, T. N. AU - Mishra, M. V. AU - Bridges, J. F. PY - 2015 DA - 2015// TI - Factors that influence patient preferences for prostate cancer management options: a systematic review JO - Patient Prefer Adherence VL - 9 UR - https://doi.org/10.2147/PPA.S83333 DO - 10.2147/PPA.S83333 ID - Showalter2015 ER - TY - JOUR AU - Stewart, K. D. PY - 2016 DA - 2016// TI - Preference for pharmaceutical formulation and treatment process attributes JO - Patient Prefer Adherence VL - 10 UR - https://doi.org/10.2147/PPA.S101821 DO - 10.2147/PPA.S101821 ID - Stewart2016 ER - TY - JOUR AU - Umar, N. PY - 2012 DA - 2012// TI - Elicitation and use of patients' preferences in the treatment of psoriasis: a systematic review JO - Acta Derm Venereol VL - 92 UR - https://doi.org/10.2340/00015555-1304 DO - 10.2340/00015555-1304 ID - Umar2012 ER - TY - JOUR AU - von Arx, L. B. AU - Kjeer, T. PY - 2014 DA - 2014// TI - The patient perspective of diabetes care: a systematic review of stated preference research JO - Patient VL - 7 UR - https://doi.org/10.1007/s40271-014-0057-0 DO - 10.1007/s40271-014-0057-0 ID - von Arx2014 ER - TY - JOUR AU - Wilke, T. PY - 2017 DA - 2017// TI - Patient preferences for oral anticoagulation therapy in atrial fibrillation: a systematic literature review JO - Patient VL - 10 UR - https://doi.org/10.1007/s40271-016-0185-9 DO - 10.1007/s40271-016-0185-9 ID - Wilke2017 ER - TY - JOUR AU - Wortley, S. PY - 2014 DA - 2014// TI - Assessing stated preferences for colorectal cancer screening: a critical systematic review of discrete choice experiments JO - Patient VL - 7 UR - https://doi.org/10.1007/s40271-014-0054-3 DO - 10.1007/s40271-014-0054-3 ID - Wortley2014 ER - TY - JOUR AU - Constantinescu, F. PY - 2009 DA - 2009// TI - Understanding why rheumatoid arthritis patient treatment preferences differ by race JO - Arthritis Rheum VL - 61 UR - https://doi.org/10.1002/art.24338 DO - 10.1002/art.24338 ID - Constantinescu2009 ER - TY - JOUR AU - Veldwijk, J. PY - 2015 DA - 2015// TI - Preferences for vaccination: does health literacy make a difference? JO - Med Decis Mak VL - 35 UR - https://doi.org/10.1177/0272989X15597225 DO - 10.1177/0272989X15597225 ID - Veldwijk2015 ER - TY - JOUR AU - van Hoorn, R. PY - 2016 DA - 2016// TI - The development of PubMed search strategies for patient preferences for treatment outcomes JO - BMC Med Res Methodol VL - 16 UR - https://doi.org/10.1186/s12874-016-0192-5 DO - 10.1186/s12874-016-0192-5 ID - van Hoorn2016 ER - TY - STD TI - Selva A SI, Zhang Y, Sanabria AJ, Pequeño S, Rigau D, Martínez L, et al. Development of a search strategy for studies about patients' values and preferences. In: Evidence-Informed Public Health: Opportunities and Challenges. Abstracts of the 22nd Cochrane Colloquium; 2014 21–26 Sep; Hyderabad, India John Wiley & Sons; 2014. ID - ref42 ER - TY - JOUR AU - Schulz, K. F. AU - Altman, D. G. AU - Moher, D. PY - 2010 DA - 2010// TI - CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials JO - BMC Med VL - 8 UR - https://doi.org/10.1186/1741-7015-8-18 DO - 10.1186/1741-7015-8-18 ID - Schulz2010 ER -